United States - English - NLM (National Library of Medicine)

curium us llc - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: kit for the preparation of technetium tc99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: kit for the preparation of technetium tc99m sestamibi injection is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. kit fo

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: technetium tc99m sestamibi is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc99m sestamibi is not indicated for breast cancer screening, to co

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: cardiolite® , kit for the preparation of technetium tc99m sestamibi for injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. cardiolite® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: miraluma® , kit for the preparation of technetium tc99m sestamibi for injection, is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpa

United States - English - NLM (National Library of Medicine)

anazaohealth corporation - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1.5 mg - sestamibi is a diagnostic agent used to assess areas of reversible myocardial ischemia in the presence or absence of infracted myocardium. evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques.

Canada - English - Health Canada

prempharm inc - amiloride hydrochloride; hydrochlorothiazide - tablet - 5mg; 50mg - amiloride hydrochloride 5mg; hydrochlorothiazide 50mg - potassium-sparing diuretics

Canada - English - Health Canada

mylan pharmaceuticals ulc - amiloride hydrochloride; hydrochlorothiazide - tablet - 5mg; 50mg - amiloride hydrochloride 5mg; hydrochlorothiazide 50mg - potassium-sparing diuretics

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dichloroxylenol 1.2% w/v

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dichloroxylenol 1.2% w/v

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dichloroxylenol 1.2%

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dichoroxylenol 1.2%w/v